Neil Yeston is Director at MIMEDX GROUP, INC. (MDXG). They have made 1 open-market trade across 1 company since 2012, most recently 2020-10-02.
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $18K since 2012, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| MDXG | 126,357 | $598K |
Shares reported on the most recent Form 4, priced at the 2020-10-05 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| MDXG | BUY | 2012-12-13 | 2012-12-18 | $3.52 | $18K | -7.9% | -2.1% | -2.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.